Skip to main content
. 2023 Nov 8;30(10-11):761–773. doi: 10.1038/s41434-023-00419-9

Fig. 10. Comparison between the results of the simulations with and without assuming additional gene therapy programs entering the pipeline.

Fig. 10

a Cumulative number of approvals. b Cumulative number of patients treated. c Cumulative spending on gene therapy. The line represents the mean and the shaded region represents the 5th and 95th percentiles of our simulation.